It is possible that through alleviating the dysregulation of adipokines and inflammatory cytokines (TNF and IL-1β) in obese conditions by hepatic focused ultrasound stimulation may, in turn, mediate beneficial effects on obesity-associated complications including food intake, leptin resistance and liver pathophysiology. This evidence concerns the gene TNF and obesity disorder.